GT BIOPHARMA, INC. Long-term Line of Credit
GT BIOPHARMA, INC. (GTBP) had Long-term Line of Credit of $31.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2022-03-28
- 2021-12-31: Long-term Line of Credit $31.00K.
- 2021-09-30: Long-term Line of Credit $31.00K.
- 2021-06-30: Long-term Line of Credit $31.00K.
- 2021-03-31: Long-term Line of Credit $31.00K.
| Period end | Long-term Line of Credit |
|---|---|
| 2021-12-31 | $31.00K 10-K · filed 2022-03-28 |
| 2021-09-30 | $31.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $31.00K 10-Q/A · filed 2021-12-29 |
| 2021-03-31 | $31.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $31.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $31.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $31.00K 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $31.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $31.00K 10-K · filed 2021-04-16 |
| 2019-09-30 | $31.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $31.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $31.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $31.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | $31.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $31.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $31.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $31.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $31.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $31.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $31.00K 10-Q · filed 2017-04-28 |
| 2016-12-31 | $31.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $31.00K 10-Q/A · filed 2018-02-28 |
| 2016-06-30 | $31.00K 10-Q/A · filed 2018-02-28 |
| 2016-03-31 | $31.00K 10-Q/A · filed 2018-02-28 |
| 2015-12-31 | $31.00K 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $28.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $28.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $28.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $28.00K 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $28.00K 10-Q · filed 2015-01-08 |
| 2014-06-30 | $28.00K 10-Q · filed 2015-01-08 |
| 2014-03-31 | $28.00K 10-Q · filed 2015-01-08 |
| 2013-12-31 | $28.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $0.00 10-Q · filed 2014-12-17 |
| 2013-06-30 | $0.00 10-Q · filed 2014-12-12 |
| 2013-03-31 | $0.00 10-Q · filed 2014-12-10 |
| 2012-12-31 | $27.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | $26.00K 10-Q · filed 2012-11-21 |
| 2012-06-30 | $26.00K 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $25.00K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $25.00K 10-K · filed 2014-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |